Business Description
Jaguar Health Inc
NAICS : 325412
SIC : 2834
ISIN : US47010C3007
Description
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | 0.1 | |||||
| Debt-to-Equity | 7.48 | |||||
| Debt-to-EBITDA | -1.12 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -9.61 | |||||
| Beneish M-Score | -3.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -80.2 | |||||
| 3-Year EBITDA Growth Rate | 79.5 | |||||
| 3-Year EPS without NRI Growth Rate | 79.5 | |||||
| 3-Year FCF Growth Rate | 74.7 | |||||
| 3-Year Book Growth Rate | -87.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.65 | |||||
| 9-Day RSI | 67.66 | |||||
| 14-Day RSI | 66.07 | |||||
| 6-1 Month Momentum % | -79.94 | |||||
| 12-1 Month Momentum % | -87.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 1.34 | |||||
| Cash Ratio | 0.46 | |||||
| Days Inventory | 1488.67 | |||||
| Days Sales Outstanding | 59.11 | |||||
| Days Payable | 941.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -433.8 | |||||
| Shareholder Yield % | -64.7 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.13 | |||||
| Operating Margin % | -347.51 | |||||
| Net Margin % | -423.11 | |||||
| FCF Margin % | -340.56 | |||||
| ROE % | -1107.18 | |||||
| ROA % | -81.72 | |||||
| ROIC % | -89.4 | |||||
| ROC (Joel Greenblatt) % | -442.46 | |||||
| ROCE % | -130.76 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.28 | |||||
| PB Ratio | 2.65 | |||||
| EV-to-EBIT | -2.32 | |||||
| EV-to-EBITDA | -2.48 | |||||
| EV-to-Revenue | 8.43 | |||||
| EV-to-FCF | -2.48 | |||||
| Earnings Yield (Greenblatt) % | -43.1 | |||||
| FCF Yield % | -64.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:JAGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jaguar Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9.761 | ||
| EPS (TTM) ($) | -3.585 | ||
| Beta | 1.27 | ||
| Volatility % | 125.75 | ||
| 14-Day RSI | 66.07 | ||
| 14-Day ATR ($) | 0.029898 | ||
| 20-Day SMA ($) | 0.126805 | ||
| 12-1 Month Momentum % | -87.45 | ||
| 52-Week Range ($) | 0.0512 - 1.22 | ||
| Shares Outstanding (Mil) | 287.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jaguar Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jaguar Health Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jaguar Health Inc Frequently Asked Questions
What is Jaguar Health Inc(JAGX)'s stock price today?
The current price of JAGX is $0.18. The 52 week high of JAGX is $1.22 and 52 week low is $0.05.
When is next earnings date of Jaguar Health Inc(JAGX)?
The next earnings date of Jaguar Health Inc(JAGX) is 2024-05-15 Est..
Does Jaguar Health Inc(JAGX) pay dividends? If so, how much?
Jaguar Health Inc(JAGX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers